SGCB and prostate cancer: A recent study shows that ERG expressed by the TMPRSS2:ERG fusion gene can directly regulate both the α1 and β1 subunits of sGC and contribute to promote the downstream effector cGMP-PKG activity in prostate cancer cells [47].